50
7. KAYNAKLAR
1) Krutmann J, Morita A: Therapeutic photomedicine: phototherapy. Fitzpatrick’s dermatology in general medicine. Eds. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ. 7. Baskı. New York, McGrawHill Medical, 2008: 2243-62.
2) Ceyhan AM, Yıldırım M. PUVA tedavisi. S.D.Ü.Tıp Fak Derg 2004; 11: 30-33. 3) Hönigsmann H, Schwarz T. Ultraviolet therapy in dermatology: Eds. Bolognia JL,
Jorizza JL, RapiniRP. 2. Baskı. Spain, Mosby Elseiver, 2008; 2053-69. 4) Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB. Risk of
cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 1979; 300: 809-13. 5) Stern RS, Nichols KT, Vkev LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study. N Engl J Med 1997; 336: 1041-5. 6) Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974; 291:1207-11. 7) Hölzle E. Physical therapy: light, cold, heat. Braun Falco’s Dermatology. Ed. Burgdorf WHC, Plewig G, Wolff HH, Landthaler M. İtalya, Springer 2009; 1594-602. 8) Kavak A, Gürlevik Z. Ultraviyole ışınım kaynakları ve dozimetri. Türkderm 2010; 44: 58-61. 9) Leitenberger J, Jacobe HT, Cruz PD Jr. Photoimmunology–illuminating the immune system through photobiology. Semin Immunopathol 2007; 29: 65-70. 10) Weichenthal M, Schwarz T. Phototherapy: how does UV work? Photodermatol Photoimmunol Photomed 2005; 21: 260-6. 11) Beissert S, Schwarz T. Role of immunomodulation in diseases responsive to phototherapy. Methods 2002; 28: 138-44. 12) Brenner M, Herzinger T, Berking C, Plewig G, Degitz K. Phototherapy and photochemotherapy of sclerosing skin diseases. Photodermatol Photoimmunol Photomed 2005; 21: 157-65. 13) Neuner P, Charvat B, Knobler R, Kirnbauer R, Schwarz A, Luger TA, Schwarz T. Cytokine release by peripheral blood mononuclear cells is affected by 8methoxypsoralen plus UV-A. Photochem Photobiol 1994; 59: 182-8.



59. SAYFAYA BENZER SAYFALAR

Siklosporin, etanersept ve PUVA tedavileri alan psoriazisli hastalarda hastalık aktivitesi ile CD26/Dipeptidil peptidaz IV ve ADA düzeylerinin korelasyonu - Sayfa 64
53 39. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001;45:487-502. 40. Dovonex Cream [package insert]. Princeton (NJ): Bristol-Myers Squibb; 2000. 41. Chandraratna RA. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis. J Am Acad Dermatol 1997;37 S:12-7. 42. Lebwohl M, Menter A, Koo J, Feldman S. Cas...
Puva ve dar bant uvb fototerapilerinin derideki etkilerinin dermoskopla izlenmesi - Sayfa 106
81. Murase JE, Lee EE, Koo J. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy Int J Dermatol 2005;44:1016-21. 82. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study. N Eng J Med 1997;366:1041-5. 83. Akay BN. Bazal Hücreli...

59. SAYFADAKI ANAHTAR KELIMELER

therapy
ultraviolet
photochem
phototherapy
study
puva


59. SAYFA ICERIGI

50
7. KAYNAKLAR
1) Krutmann J, Morita A: Therapeutic photomedicine: phototherapy. Fitzpatrick’s dermatology in general medicine. Eds. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ. 7. Baskı. New York, McGrawHill Medical, 2008: 2243-62.
2) Ceyhan AM, Yıldırım M. PUVA tedavisi. S.D.Ü.Tıp Fak Derg 2004; 11: 30-33. 3) Hönigsmann H, Schwarz T. Ultraviolet therapy in dermatology: Eds. Bolognia JL,
Jorizza JL, RapiniRP. 2. Baskı. Spain, Mosby Elseiver, 2008; 2053-69. 4) Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB. Risk of
cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 1979; 300: 809-13. 5) Stern RS, Nichols KT, Vkev LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study. N Engl J Med 1997; 336: 1041-5. 6) Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974; 291:1207-11. 7) Hölzle E. Physical therapy: light, cold, heat. Braun Falco’s Dermatology. Ed. Burgdorf WHC, Plewig G, Wolff HH, Landthaler M. İtalya, Springer 2009; 1594-602. 8) Kavak A, Gürlevik Z. Ultraviyole ışınım kaynakları ve dozimetri. Türkderm 2010; 44: 58-61. 9) Leitenberger J, Jacobe HT, Cruz PD Jr. Photoimmunology–illuminating the immune system through photobiology. Semin Immunopathol 2007; 29: 65-70. 10) Weichenthal M, Schwarz T. Phototherapy: how does UV work? Photodermatol Photoimmunol Photomed 2005; 21: 260-6. 11) Beissert S, Schwarz T. Role of immunomodulation in diseases responsive to phototherapy. Methods 2002; 28: 138-44. 12) Brenner M, Herzinger T, Berking C, Plewig G, Degitz K. Phototherapy and photochemotherapy of sclerosing skin diseases. Photodermatol Photoimmunol Photomed 2005; 21: 157-65. 13) Neuner P, Charvat B, Knobler R, Kirnbauer R, Schwarz A, Luger TA, Schwarz T. Cytokine release by peripheral blood mononuclear cells is affected by 8methoxypsoralen plus UV-A. Photochem Photobiol 1994; 59: 182-8.

İlgili Kaynaklar

single.php